The present invention relates to a tablet formulation comprising a combination of dapoxetine or a pharmaceutically acceptable salt thereof with tadalafil or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for preparing such a formulation and to the use thereof in the treatment of premature ejaculation.